Compare EDSA & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EDSA | SSKN |
|---|---|---|
| Founded | 2015 | 1989 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 8.9M |
| IPO Year | N/A | 2005 |
| Metric | EDSA | SSKN |
|---|---|---|
| Price | $1.47 | $1.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $13.00 | $6.00 |
| AVG Volume (30 Days) | 37.8K | ★ 70.8K |
| Earning Date | 12-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,980,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.28 | $1.19 |
| 52 Week High | $4.49 | $3.86 |
| Indicator | EDSA | SSKN |
|---|---|---|
| Relative Strength Index (RSI) | 40.04 | 48.29 |
| Support Level | $1.27 | $1.19 |
| Resistance Level | $1.50 | $1.31 |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 36.36 | 50.00 |
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.